Finance

Lists
301301:SHE
Yili Chuanning Biotechnology Co Ltd
CNÂ¥8.78
+1.62%
(+0.14) 1D
Sep 1, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301301...
Open
CNÂ¥8.65
High
CNÂ¥8.89
Low
CNÂ¥8.63
Mkt. cap
19.58B
Avg. vol.
15.10M
Volume
16.22M
Dividend
1.97%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Apr 29, 2026
P/E ratio
34.25
52-wk high
CNÂ¥12.90
52-wk low
CNÂ¥7.69
EPS
CNÂ¥0.26
Shares outstanding
2.23B
No. of employees
3K
Open
CNÂ¥8.65
High
CNÂ¥8.89
Low
CNÂ¥8.63
Mkt. cap
19.58B
Avg. vol.
15.10M
Volume
16.22M
Dividend
1.97%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Apr 29, 2026
P/E ratio
34.25
52-wk high
CNÂ¥12.90
52-wk low
CNÂ¥7.69
EPS
CNÂ¥0.26
Shares outstanding
2.23B
No. of employees
3K
About Yili Chuanning Biotechnology Co Ltd
CEO-
Employees3.13K
FoundedDec 10, 2010
Headquarters-
SectorBiotechnology
Websiteklcnsw.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.09B
1.18B
1.09B
1.00B
Cost of goods sold
775.99M
981.03M
836.67M
720.54M
Cost of revenue
775.99M
981.03M
836.67M
720.54M
Research and development expenses
16.00M
18.85M
22.09M
17.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.83M
4.30M
64.17M
35.39M
Operating expense
75.86M
45.95M
103.10M
73.21M
Total operating expenses
851.85M
1.03B
939.77M
793.75M
Operating income
235.55M
153.30M
154.73M
209.48M
Other non operating income
-10.94M
9.26M
-8.98M
8.64M
EBT including unusual items
192.27M
186.91M
138.71M
198.60M
EBT excluding unusual items
212.88M
159.94M
137.49M
201.32M
Income tax expense
35.94M
29.47M
28.69M
34.53M
Effective tax rate
18.69%
15.77%
20.68%
17.39%
Other operating expenses
1.01M
27.22M
17.15M
18.07M
Net income
156.53M
157.62M
110.73M
166.78M
Net profit margin
14.40%
13.35%
10.12%
16.62%
Earnings per share
-
-
-
-
Interest and investment income
897.08K
752.74K
674.20K
856.59K
Interest expense
-9.41M
-3.00M
-8.93M
-9.39M
Net interest expenses
-8.52M
-2.25M
-8.25M
-8.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
370.98M
295.77M
297.20M
356.20M
Gain or loss from assets sale
352.14K
-345.96K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps